As a person who has struggled with a cigarette addiction for more than 40 years, annual low-dose CT scans likely saved my ...

PEF is a newer treatment option for various cancers in the lungs that have failed first-line treatment. It can be offered for ...

Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with ...

Media ReleaseEntered into strategic collaboration with Dr. Reddy’s for commercialisation of eftilagimod alfa (efti) in all countries outside ...

Invenio Imaging, an innovator in fresh tissue imaging and artificial intelligence, today announced the appointment of Adrian Whitford as an Independent Board Director. The company also welcomed Biao ...

A consultant surgeon has concluded that “substandard primary treatment” carried out by a doctor at the former Erne Hospital had a ...

Mesothelioma early symptoms include fluid buildup and difficulty breathing. Learn how to recognize the early signs of ...

Population aging is reshaping the landscape of respiratory disease, with COPD, idiopathic pulmonary fibrosis, bronchiectasis, ...

Cancer treatment is entering a new era, driven by advances in precision medicine, AI, and targeted therapies known as theranostics. In this episode of Today in Tech, Keith Shaw speaks with Douglas ...

The main pulmonary artery diameter, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in patients with connective tissue disease-associated PAH.

Radon gas, an invisible health threat that can build up in your home, is putting more Canadians at risk of deadly lung cancer ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...